Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014 Jan;55(1):95-8.
doi: 10.2967/jnumed.113.127266. Epub 2013 Sep 27.

Clinical Cerenkov luminescence imaging of (18)F-FDG

Affiliations
Observational Study

Clinical Cerenkov luminescence imaging of (18)F-FDG

Daniel L J Thorek et al. J Nucl Med. 2014 Jan.

Abstract

The aim of this study was to determine the feasibility of Cerenkov luminescence (CL) imaging of patients undergoing diagnostic (18)F-FDG scans to detect nodal disease.

Methods: Patients undergoing routine (18)F-FDG PET/CT for various malignancies consented to being scanned for CL. White-light and Cerenkov images (5-min acquisition) of the surface of the patient contralateral to and at the site of nodal (18)F-FDG uptake were acquired using a cooled, intensified charge-coupled-device camera.

Results: The camera demonstrated linear correlation between activity and counts into the low nanocurie range using (18)F-FDG. Imaging of patients revealed the presence of (18)F-FDG uptake in nodes that demonstrated uptake on PET. A correlation between maximum standardized uptake value from PET and counting rate per area on the CL imaging was established.

Conclusion: CL imaging with diagnostic doses of (18)F-FDG is feasible and can aid in detecting disease in the clinical setting.

Keywords: 18F-FDG; Cerenkov luminescence imaging; PET/CT; clinical.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

No other potential conflict of interest relevant to this article was reported.

Figures

FIGURE 1
FIGURE 1
Sensitivity and linearity of intensified CCD to detect CL from 18F-FDG. (A) CL imaging of multiwell plate with activity at 1 and 0.1 MBq/mL. (B) Linearity analysis of background-subtracted and decay-corrected region of interest of CL photon flux from wells using intensified CCD with settings optimized for the activity concentrations.
FIGURE 2
FIGURE 2
Representative CL and PET/CT images of 18F-FDG–positive axillary lymph node. (A and B) CL scans of right and left axillae, respectively. (C) Negative CL scan in light-protected environment of right axilla without 18F-FDG–positive lymph node, overlaid with white-light photograph. No significant CL emission from 18F-FDG decay is seen. (D) White-light photograph from left axilla, overlaid with significant CL signal (B). (E) This signal colocalized with PET/CT finding.
FIGURE 3
FIGURE 3
(A) Correlation graph between PET (MBq/mL max) and CL imaging count rate. (B) Box plot comparing Cerenkov emission from pathologic, PET-positive lymph nodes vs. contralateral PET-negative control, demonstrating significantly higher signal from PET-positive side.

Comment in

  • Reply: Human Cerenkov imaging using 18F-FDG.
    Thorek DL, Riedl CC, Grimm J. Thorek DL, et al. J Nucl Med. 2014 Mar;55(3):523-4. doi: 10.2967/jnumed.113.135533. Epub 2014 Jan 21. J Nucl Med. 2014. PMID: 24449595 No abstract available.
  • Human Cerenkov imaging using 18F-FDG.
    Spinelli AE, Boschi F. Spinelli AE, et al. J Nucl Med. 2014 Mar;55(3):523. doi: 10.2967/jnumed.113.135384. Epub 2014 Jan 21. J Nucl Med. 2014. PMID: 24449596 No abstract available.

References

    1. Ntziachristos V, Ripoll J, Wang LV, Weissleder R. Looking and listening to light. Nat Biotechnol. 2005;23:313–320. - PubMed
    1. Willmann JK, van Bruggen N, Dinkelborg LM, Gahbhir SS. Molecular imaging in drug development. Nat Rev Drug Discov. 2008;7:591–607. - PubMed
    1. Byrne WL, Delille A, Kuo C, et al. Use of optical imaging to progress novel therapeutics to the clinic. J Control Release. 2013 May 13; Epub ahead of print. - PubMed
    1. Cho JS, Taschereau R, Olma S, et al. Cerenkov radiation imaging as a method for quantitative measurements of beta particles in a microfluidic chip. Phys Med Biol. 2009;54:6757–6771. - PMC - PubMed
    1. Spinelli AE, D’Ambrosio D, Calderan L, Marengo M, Sbarbati A, Boschi F. Cerenkov radiation allows in vivo optical imaging of positron emitting radio-tracers. Phys Med Biol. 2010;55:483–495. - PubMed

Publication types

Substances